Selected article for: "serum determine and time period"

Author: Giuseppe Gritti; Federico Raimondi; Diego Ripamonti; Ivano Riva; Francesco Landi; Leonardo Alborghetti; Marco Frigeni; Marianna Damiani; Caterina Micò; Stefano Fagiuoli; Roberto Cosentini; Ferdinando Luca Lorini; Fabrizio Fabretti; Jonathan Morgan; Benjamin M.J. Owens; Karan Kanhai; Jim Cowburn; Marco Rizzi; Fabiano Di Marco; Alessandro Rambaldi
Title: Use of siltuximab in patients with COVID-19 pneumonia requiring ventilatory support
  • Document date: 2020_4_3
  • ID: ajurlkwr_32
    Snippet: The copyright holder for this preprint . https: //doi.org/10.1101 //doi.org/10. /2020 The limitations of this report include that the compassionate-use program was set-up in a short period of time, to determine the effectiveness of siltuximab to reduce serum CRP levels, and understand whether IL-6 and CRP levels can be controlled to improve the outcomes for patients with pneumonia/ARDS associated with COVID-19. In addition, the report includes a .....
    Document: The copyright holder for this preprint . https: //doi.org/10.1101 //doi.org/10. /2020 The limitations of this report include that the compassionate-use program was set-up in a short period of time, to determine the effectiveness of siltuximab to reduce serum CRP levels, and understand whether IL-6 and CRP levels can be controlled to improve the outcomes for patients with pneumonia/ARDS associated with COVID-19. In addition, the report includes a short follow-up period with a limited number of patients.

    Search related documents:
    Co phrase search for related documents